Treosulfan–fludarabine‐based conditioning was associated with favourable event‐free survival and very low risk of endothelial cell dysfunction in paediatric patients with non‐malignant haematological disorders: Analysis of the UK Paediatric Treosulfan Study

Documenti analoghi

• Treosulfan–fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study
  di: Su Han Lum, et al.
  Pubblicazione: (2026)
• Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post‐transplant cyclophosphamide era: A GETH ‐ TC study
  di: Marta Peña, et al.
  Pubblicazione: (2026)
• Real‐world experience of paediatric acute promyelocytic leukaemia in the United Kingdom and Ireland
  di: Aditi Vedi, et al.
  Pubblicazione: (2024)
• The association of thrombocytopenia with haematological malignancy
  di: Abi Vijenthira, et al.
  Pubblicazione: (2026)
• Artificial intelligence for risk assessment and outcome prediction in malignant haematology
  di: Jan‐Niklas Eckardt, et al.
  Pubblicazione: (2025)